CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-22 | McBride John S. Chief Operating Officer | Sale | −2,000 | $14.02 | $28K | 0 |
| 2015-06-22 | McBride John S. Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,000 | 207,178 | ||
| 2015-06-17 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-06-17 | Yanchik Joseph A., III Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-06-17 | Kessler David A. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-06-17 | Harrison Seth Loring Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-06-17 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-06-16 | Novartis Bioventures Ltd 10% owner | Sale | −1,120 | $14.27 | $16K | 4,545,496 |
| 2015-06-12 | Novartis Bioventures Ltd 10% owner | Sale | −5,919 | $14.20 | $84K | 4,561,393 |
| 2015-06-11 | Novartis Bioventures Ltd 10% owner | Sale | −27,875 | $14.20 | $396K | 4,567,312 |
| 2015-05-26 | Quirk Gerald E General Counsel, Executive VP | Grant or award · Stock Option (right to buy) | +214,605 | 214,605 | ||
| 2015-04-16 | Kalowski Lee Chief Financial Officer | Sale | −4,567 | $13.00 | $59K | 47,779 |
| 2015-04-09 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2015-04-02 | Kalowski Lee Chief Financial Officer | Sale | −2,258 | $11.45 | $26K | 52,346 |
| 2015-03-19 | Novartis Bioventures Ltd 10% owner | Sale | −46,141 | $14.50 | $669K | 4,595,187 |
| 2015-03-18 | Novartis Bioventures Ltd 10% owner | Sale | −3,000 | $14.50 | $44K | 4,641,328 |
| 2015-01-08 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2014-10-15 | Morrison Jodie Pope President and CEO | Grant or award · Stock Option (right to buy) | +134,134 | 134,134 | ||
| 2014-10-15 | McBride John S. Chief Operating Officer | Grant or award · Stock Option (right to buy) | +50,671 | 50,671 | ||
| 2014-09-22 | Satter Muneer A 10% owner | Conversion | +1,621,688 | 1,621,688 |
Page 13 of 15 · 300 trades